Work

In vivo efficacy of a refillable intrawound drug delivery device in a sheep model of biofilm-compromised open fracture-related infection

Year: 2025
Type: article
Abstract: CFU. The hypothesis was supported. The Pouch received Breakthrough Device Designation by the FDA, is being transitioned toward clinical trials, and is a potential solution to the long-standing problem of open fracture-related infection.
Source: Biofilm
Language: English
Subfield: Surgery
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,140
OpenAlex ID: W4407461931
FWCI: 5.182
Cites: 71
Cited by: 6
Related to: 10